Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline sustained-release tablets in convalescent cerebral infarction
ChiCTR2000041348Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pentoxifylline in brain infarction and ischemic stroke (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: NIHSS score at 12 weeks. Started Jan 2021; status: recruiting.
02
Drugs
pentoxifylline
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on ChiCTR2000041348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041348.